Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Polycystic Ovary Syndrome × Tirzepatide × Other × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Obesity 9 Endometrial Neoplasms 3 Overweight 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Metabolic Syndrome 1 Insulin Resistance 1 Inflammation 1 Hyperplasia 1 Endometrial Hyperplasia 1 Dyslipidemias 1 Diabetes Mellitus 1 Colorectal Neoplasms 1 Breast Neoplasms 1

Interventions

Metformin 16 Liraglutide 5 semaglutide 3 Exercise 3 Exenatide 3 Diet, Mediterranean 3 Dexamethasone 3 Caloric Restriction 3 Ovidrel 2 Mindfulness-Based Stress Reduction 2 Hydrocortisone 2 Electroacupuncture 2 Docosahexaenoic Acids 2 Diet 2 Cosyntropin 2 sibutramine 1 penclomedine 1 mirabegron 1 lime 1 licogliflozin 1 dapagliflozin 1 Vitamin D 1 Utrogestan 1 Topiramate 1 Tirzepatide 1 Therapeutics 1 Testosterone 1 Surveys and Questionnaires 1 Standard of Care 1 Spironolactone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07326111 2026-01-08

PERIODS

University of Bonn

Phase 4 Recruiting

Obesity, Polycystic Ovary Syndrome, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon ⚡